Pioneering Healthcare Company changes name from Brainshake to “Nightingale Health”

After three years of fast growing business in the medical research market, the company known as Brainshake has unveiled its new company name, Nightingale Health. This coincides directly with the company’s move in 2017 to clinical testing in Europe. With its unique, proprietary and powerful blood testing re-invention, Nightingale aims to solve the world’s biggest health problem. The technology has been proven to advance research in chronic diseases such as heart disease and diabetes, and is supported by over 100 peer-reviewed biomedical publications. When asked about the new name, CEO Teemu Suna said:

“We have been laser focused on this revolutionary product and as we move to making it widely available, we wanted a name that truly reflects our mission, passion and values. The Nightingale bird in the Finnish translation literally means “representing many voices”. At the same time, Florence Nightingale was one of the original pioneers of modern medicine; instead of taking medical interventions as the only solution, she introduced better hygiene and nursing practice for disease prevention. In addition, she popularized visual data mapping, she was a believer in better healthcare for all. She took action, did not accept the status quo and innovated new thinking. As an inclusive and pioneering company, we are inspired by her work”.

The company will refresh its brand look and feel and as CCO Kristiina Tolvanen explains: “We are proud to pioneer new solutions in everything we do. And this will be reflected in our identity over the coming months”.

The company simultaneously remains tirelessly focused on making their unique blood analysis solution scale with affordability, clinical integration and scalability as core foundations. Nightingale’s mission is to make life defining choices possible so rather than just diagnosing and treating diseases, we will be able to take preventive actions.

Recently, Nightingale Health’s blood analysis technology has been chosen from hundreds of applications to be presented at MIT Solve event at United Nations headquarters in March.

Further information:

Teemu Suna, CEO, Co-founder

+358 40 196 1669

Solve at the United Nations -event:

Nightingale Health Ltd. 

Nightingale Health (formerly known as Brainshake) is a pioneering healthcare company aiming to solve the world’s biggest health problem with its unique, proprietary and powerful blood testing re-invention. The technology has been proven to advance scientific research in chronic diseases and is supported by over 100 peer-reviewed biomedical publications. Early prediction and prevention of heart disease and diabetes is at the core of the technology. Nightingale’s mission is to make life defining choices possible, so that in the future we are no longer just told and diagnosed, we can predict our health.

About Us

Nightingale Health Ltd. is the innovator of an internationally recognized NMR (Nuclear Magnetic Resonance) based biomarker analysis assay for early disease detection. Our aim is to solve the growing burden of cardiovascular disease and diabetes, accounting for healthcare costs of over 1.6 trillion dollars annually. Our pioneering precision medicine services, include: effective chronic disease screening, health diagnostics and improving treatment efficacy. By providing our customers with accurate health data, we plan to help empower patients to follow-up on their own well-being and take proactive steps to stay healthy. For more information, please visit